TY - JOUR A1 - Warschburger, Petra A1 - Kröller, Katja T1 - "Childhood overweight and obesity maternal perceptions of the time for engaging in child weight management" JF - BMC public health N2 - Background: There is an increasing awareness of the impact of parental risk perception on the weight course of the child and the parent's readiness to engage in preventive efforts, but only less is known about factors related to the parental perception of the right time for the implementation of preventive activities. The aim of this study was to examine parental perceptions of the appropriate time to engage in child weight management strategies, and the factors associated with different weight points at which mothers recognize the need for preventive actions. Methods: 352 mothers with children aged 2-10 years took part in the study. We assessed mothers' perceptions of the actual and preferred weight status of their child, their ability to identify overweight and knowledge of its associated health risks, as well as perceptions of the right time for action to prevent overweight in their child. A regression analysis was conducted to examine whether demographic and weight related factors as well as the maternal general risk perception were associated with recognizing the need to implement prevention strategies. Results: Although most of the parents considered a BMI in the 75th to 90th percentile a valid reason to engage in the prevention of overweight, 19% of the mothers were not willing to engage in prevention until their child reached the 97th percentile. Whereas the child's sex and the identification of an elevated BMI were significant predictors for parents' recognition of the 75th percentile as right point to engage in prevention efforts, an inability to recognize physical health risks associated with overweight silhouettes emerged as a significant factor predicting which parents would delay prevention efforts until a child's BMI reached the 97th percentile. Conclusion: Parental misperceptions of overweight and associated health risks constitute unfavorable conditions for preventive actions. Feedback on the health risks associated with overweight could help increase maternal readiness for change. KW - Maternal perception KW - Need for action KW - Prevention KW - Obesity KW - Overweight KW - Children Y1 - 2012 U6 - https://doi.org/10.1186/1471-2458-12-295 SN - 1471-2458 VL - 12 IS - 12 PB - BioMed Central CY - London ER - TY - GEN A1 - Koziel, Slawomir A1 - Hermanussen, Michael A1 - Gomula, Alexandra A1 - Swanson, James A1 - Kaczmarek, Maria A1 - El-Shabrawi, Mortada A1 - Elhusseini, Mona A1 - Satake, Takashi A1 - Martinovic Klaric, Irena A1 - Scheffler, Christiane A1 - Morkuniene, Ruta A1 - Godina, Elena A1 - Sasa, Missoni A1 - Tutkuviene, Janina A1 - Siniarska, Anna A1 - Nieczuja-Dwojacka, Joanna A1 - Nunez, Javier A1 - Groth, Detlef A1 - Barbieri, Davide T1 - Adolescence - a Transition to Adulthood Proceedings of the 24th Aschauer Soiree, held at Jurata, Poland, November 5th 2016 T2 - Pediatric Endocrinology Reviews N2 - Eighteen scientists met at Jurata, Poland, to discuss various aspects of the transition from adolescence to adulthood. This transition is a delicate period facing complex interactions between the adolescents and the social group they belong to. Social identity, group identification and identity signalling, but also stress affecting basal salivary cortisol rhythms, hypertension, inappropriate nutrition causing latent and manifest obesity, moreover, in developing and under-developed countries, parasitosis causing anaemia thereby impairing growth and development, are issues to be dealt with during this period of the human development. In addition, some new aspects of the association between weight, height and head circumference in the newborns were discussed, as well as intrauterine head growth and head circumference as health risk indicators. KW - Strategic growth adjustment KW - BMI KW - Growth faltering KW - Secular trend KW - Obesity KW - Growth modelling Y1 - 2017 SN - 1565-4753 VL - 14 IS - 3 SP - 326 EP - 334 PB - Medical Media CY - Netanya ER - TY - JOUR A1 - Warschburger, Petra A1 - Gmeiner, Michaela Silvia A1 - Morawietz, Marisa A1 - Rinck, Mike T1 - Battle of plates BT - a pilot study of an approach-avoidance training for overweight children and adolescents JF - Public health nutrition : PHN / The Nutrition Society N2 - Objective: Approach-avoidance training (AAT) is a promising approach in obesity treatment. The present study examines whether an AAT is feasible and able to influence approach tendencies in children and adolescents, comparing implicit and explicit training approaches. Design/Setting/Subjects: Fifty-nine overweight children and adolescents (aged 8-16 years; twenty-six boys) participated in an AAT for food cues, learning to reject snack items and approach vegetable items. Reaction times in the AAT and an implicit association rest (IAT) were assessed pre- and post-intervention. Results: A significant increase in the AAT compatibility scores with a large effect (eta(2) = 0.18) was found. No differences between the implicit and explicit training approaches and no change in the IAT scores were observed. Conclusions: Automatic tendencies in children can be trained, too. The implementation of AAT in the treatment of obesity might support the modification of an unhealthy nutrition behaviour pattern. Further data from randomized controlled clinical trials are needed. KW - Approach-avoidance KW - Intervention KW - Child KW - Obesity KW - Feasibility study Y1 - 2017 U6 - https://doi.org/10.1017/S1368980017002701 SN - 1368-9800 SN - 1475-2727 VL - 21 IS - 2 SP - 426 EP - 434 PB - Cambridge Univ. Press CY - Cambridge ER - TY - JOUR A1 - Hoffmann, Svenja A1 - Warschburger, Petra T1 - Body image in obese children and adolescents. Body dissatisfaction and body size perception in relation to quality of life and weight loss JF - Psychotherapeut N2 - Body dissatisfaction and an unrealistic perception of own body size are particularly common in obese children and adolescents; however, little is known about the association with weight-related quality of life and the impact on successful long-term weight loss. At the beginning of an inpatient child obesity rehabilitation program, 408 children and adolescents aged 9-12 years completed a questionnaire on body image (body silhouettes) and a body weight-specific questionnaire for overweight and obese children and adolescents (GW-LQ-KJ) on quality of life. Height and weight were measured by a physician at the beginning and 1 year after inpatient hospitalization. Of the participants 91.9 % reported body dissatisfaction and 75.7 % underestimated their own body size. There were no gender-specific differences in body dissatisfaction but boys perceived their body size more realistically than girls. Participants with body dissatisfaction and realistic body size perception showed a reduced weight-related quality of life. Those participants who realistically perceived their body size also lost less weight in the long term. The subjective underestimation of body size proved to be important for reduced weight-related quality of life and more pronounced long-term weight loss; therefore, body image should be taken into account in multimodal treatment programs. KW - Body size perception KW - Quality of life KW - Weight loss KW - Obesity KW - Questionnaire Y1 - 2015 U6 - https://doi.org/10.1007/s00278-015-0060-5 SN - 0935-6185 SN - 1432-2080 VL - 60 IS - 6 SP - 498 EP - 504 PB - Springer CY - New York ER - TY - JOUR A1 - Mumm, Rebekka A1 - Scheffler, Christiane A1 - Hermanussen, Michael T1 - Developing differential height, weight and body mass index references for girls that reflect the impact of the menarche JF - Acta paediatrica : nurturing the child N2 - Aim Growth is both a matter of amplitude and tempo. We aimed to develop references for body height, body weight and body mass index (BMI) with respect to tempo of maturity. Methods Data obtained from the German KiGGS study (2003-2006) on body height, body weight and presence or absence of the menarche were re-analysed in 3776 girls, aged 10-17years. We developed smoothed centiles for BMI-, body-height- and body-weight-for-age using the LMS method for premenarcheal and postmenarcheal girls. Results Body height, body weight and BMI differed significantly between premenarcheal and postmenarcheal girls. On average, postmenarcheal girls aged 11-17years were 5.3cm taller and 9.7kg heavier, and their BMI was 2.9kg/m2 higher than in premenarcheal girls of the same calendar age. Conclusion Adolescent BMI rises with calendar age and biological age. New reference charts for adolescent girls aged 10-18years were generated to be inserted into the currently used references to avoid misclassifying underweight and overweight pubertal girls. KW - Body mass index KW - Body mass index reference values KW - Menarche KW - Obesity KW - Overweight Y1 - 2014 U6 - https://doi.org/10.1111/apa.12625 SN - 0803-5253 SN - 1651-2227 VL - 103 IS - 7 SP - e312 EP - e316 PB - Wiley-Blackwell CY - Hoboken ER - TY - JOUR A1 - Laeger, Thomas A1 - Castano-Martinez, Teresa A1 - Werno, Martin W. A1 - Japtok, Lukasz A1 - Baumeier, Christian A1 - Jonas, Wenke A1 - Kleuser, Burkhard A1 - Schürmann, Annette T1 - Dietary carbohydrates impair the protective effect of protein restriction against diabetes in NZO mice used as a model of type 2 diabetes JF - Diabetologia : journal of the European Association for the Study of Diabetes (EASD) N2 - Aims/hypothesis Low-protein diets are well known to improve glucose tolerance and increase energy expenditure. Increases in circulating fibroblast growth factor 21 (FGF21) have been implicated as a potential underlying mechanism. Methods We aimed to test whether low-protein diets in the context of a high-carbohydrate or high-fat regimen would also protect against type 2 diabetes in New Zealand Obese (NZO) mice used as a model of polygenetic obesity and type 2 diabetes. Mice were placed on high-fat diets that provided protein at control (16 kJ%; CON) or low (4 kJ%; low-protein/high-carbohydrate [LP/HC] or low-protein/high-fat [LP/HF]) levels. Results Protein restriction prevented the onset of hyperglycaemia and beta cell loss despite increased food intake and fat mass. The effect was seen only under conditions of a lower carbohydrate/fat ratio (LP/HF). When the carbohydrate/fat ratio was high (LP/HC), mice developed type 2 diabetes despite the robustly elevated hepatic FGF21 secretion and increased energy expenditure. Conclusion/interpretation Prevention of type 2 diabetes through protein restriction, without lowering food intake and body fat mass, is compromised by high dietary carbohydrates. Increased FGF21 levels and elevated energy expenditure do not protect against hyperglycaemia and type 2 diabetes per se. KW - Energy expenditure KW - FGF21 KW - Hyperglycaemia KW - Insulin resistance KW - NZO KW - Obesity KW - Protein restriction Y1 - 2018 U6 - https://doi.org/10.1007/s00125-018-4595-1 SN - 0012-186X SN - 1432-0428 VL - 61 IS - 6 SP - 1459 EP - 1469 PB - Springer CY - New York ER - TY - JOUR A1 - Warschburger, Petra A1 - Kröller, Katja A1 - Haerting, Johannes A1 - Unverzagt, Susanne A1 - van Egmond-Fröhlich, Andreas T1 - Empowering Parents of Obese Children (EPOC): A randomized controlled trial on additional long-term weight effects of parent training JF - Appetite : multidisciplinary research on eating and drinking N2 - Although inpatient lifestyle treatment for obese children and adolescents can be highly effective in the short term, long-term results are unconvincing. One possible explanation might be that the treatment takes place far from parents' homes, limiting the possibility to incorporate the parents, who play a major role in establishing and maintaining a healthy lifestyle in childhood and adolescence. The main goal was to develop a brief behaviorally oriented parent training program that enhances ‘obesity-specific’ parenting skills in order to prevent relapse. We hypothesized that the inclusion of additional parent training would lead to an improved long-term weight course of obese children. Parents of obese children (n = 686; 7–13 years old) either participated in complementary cognitive-behavioral group sessions (n = 336) or received written information only (n = 350) during the inpatient stay. Children of both groups attended multidisciplinary inpatient rehabilitation. BMI-SDS as a primary outcome was evaluated at baseline, post-intervention and at 6- and 12-month follow-up. Intention-to-treat (ITT) as well as per-protocol analyses (PPA) were performed. A significant within-group decrease of 0.24 (95% CI 0.18 to 0.30) BMI-SDS points from the beginning of the inpatient stay through the first year was found, but no group difference at the one-year follow-up (mean difference 0.02; 95% CI -0.04 to 0.07). We also observed an increase in quality of life scores, intake of healthy food and exercise for both groups, without differences between groups (ITT and PPA). Thus, while the inpatient treatment proved highly effective, additional parent training did not lead to better results in long-term weight maintenance or to better psychosocial well-being compared to written psycho-educational material. Further research should focus on subgroups to answer the question of differential treatment effects. KW - Obesity KW - Children KW - Randomized controlled trial KW - Weight KW - Parent training KW - Quality of life Y1 - 2016 U6 - https://doi.org/10.1016/j.appet.2016.04.007 SN - 0195-6663 SN - 1095-8304 VL - 103 SP - 148 EP - 156 PB - Elsevier CY - London ER - TY - JOUR A1 - Caliendo, Marco A1 - Lee, Wang-Sheng T1 - Fat chance! - Obesity and the transition from unemployment to employment JF - Economics and human biology N2 - This paper focuses on estimating the magnitude of any potential weight discrimination by examining whether obese job applicants in Germany get treated or behave differently from non-obese applicants. Based on two waves of rich survey data from the IZA Evaluation dataset, which includes measures that control for education, demographic characteristics, labor market history, psychological factors and health, we estimate differences in job search behavior and labor market outcomes between obese/overweight and normal weight individuals. Unlike other observational studies which are generally based on obese and non-obese individuals who might already be at different points in the job ladder (e.g., household surveys), in our data, individuals are newly unemployed and all start from the same point. The only subgroup we find in our data experiencing any possible form of negative labor market outcomes is obese women. Despite making more job applications and engaging more in job training programs, we find some indications that they experienced worse (or at best similar) employment outcomes than normal weight women. Obese women who found a job also had significantly lower wages than normal weight women. KW - Obesity KW - Discrimination KW - Employment KW - Labor demand Y1 - 2013 U6 - https://doi.org/10.1016/j.ehb.2012.02.002 SN - 1570-677X VL - 11 IS - 2 SP - 121 EP - 133 PB - Elsevier CY - Amsterdam ER - TY - GEN A1 - Hauffe, Robert A1 - Rath, Michaela A1 - Schell, Mareike A1 - Ritter, Katrin A1 - Kappert, Kai A1 - Deubel, Stefanie A1 - Ott, Christiane A1 - Jähnert, Markus A1 - Jonas, Wenke A1 - Schürmann, Annette A1 - Kleinridders, André T1 - HSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue T2 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe N2 - Objective Insulin regulates mitochondrial function, thereby propagating an efficient metabolism. Conversely, diabetes and insulin resistance are linked to mitochondrial dysfunction with a decreased expression of the mitochondrial chaperone HSP60. The aim of this investigation was to determine the effect of a reduced HSP60 expression on the development of obesity and insulin resistance. Methods Control and heterozygous whole-body HSP60 knockout (Hsp60+/−) mice were fed a high-fat diet (HFD, 60% calories from fat) for 16 weeks and subjected to extensive metabolic phenotyping. To understand the effect of HSP60 on white adipose tissue, microarray analysis of gonadal WAT was performed, ex vivo experiments were performed, and a lentiviral knockdown of HSP60 in 3T3-L1 cells was conducted to gain detailed insights into the effect of reduced HSP60 levels on adipocyte homeostasis. Results Male Hsp60+/− mice exhibited lower body weight with lower fat mass. These mice exhibited improved insulin sensitivity compared to control, as assessed by Matsuda Index and HOMA-IR. Accordingly, insulin levels were significantly reduced in Hsp60+/− mice in a glucose tolerance test. However, Hsp60+/− mice exhibited an altered adipose tissue metabolism with elevated insulin-independent glucose uptake, adipocyte hyperplasia in the presence of mitochondrial dysfunction, altered autophagy, and local insulin resistance. Conclusions We discovered that the reduction of HSP60 in mice predominantly affects adipose tissue homeostasis, leading to beneficial alterations in body weight, body composition, and adipocyte morphology, albeit exhibiting local insulin resistance. T3 - Zweitveröffentlichungen der Universität Potsdam : Mathematisch-Naturwissenschaftliche Reihe - 1235 KW - Mitochondria KW - Stress response KW - Obesity KW - Glucose homeostasis KW - Insulin resistance KW - Adipose tissue Y1 - 2022 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-548002 SN - 1866-8372 SP - 1 EP - 14 PB - Universitätsverlag Potsdam CY - Potsdam ER - TY - JOUR A1 - Hauffe, Robert A1 - Rath, Michaela A1 - Schell, Mareike A1 - Ritter, Katrin A1 - Kappert, Kai A1 - Deubel, Stefanie A1 - Ott, Christiane A1 - Jähnert, Markus A1 - Jonas, Wenke A1 - Schürmann, Annette A1 - Kleinridders, André T1 - HSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue JF - Molecular Metabolism N2 - Objective Insulin regulates mitochondrial function, thereby propagating an efficient metabolism. Conversely, diabetes and insulin resistance are linked to mitochondrial dysfunction with a decreased expression of the mitochondrial chaperone HSP60. The aim of this investigation was to determine the effect of a reduced HSP60 expression on the development of obesity and insulin resistance. Methods Control and heterozygous whole-body HSP60 knockout (Hsp60+/−) mice were fed a high-fat diet (HFD, 60% calories from fat) for 16 weeks and subjected to extensive metabolic phenotyping. To understand the effect of HSP60 on white adipose tissue, microarray analysis of gonadal WAT was performed, ex vivo experiments were performed, and a lentiviral knockdown of HSP60 in 3T3-L1 cells was conducted to gain detailed insights into the effect of reduced HSP60 levels on adipocyte homeostasis. Results Male Hsp60+/− mice exhibited lower body weight with lower fat mass. These mice exhibited improved insulin sensitivity compared to control, as assessed by Matsuda Index and HOMA-IR. Accordingly, insulin levels were significantly reduced in Hsp60+/− mice in a glucose tolerance test. However, Hsp60+/− mice exhibited an altered adipose tissue metabolism with elevated insulin-independent glucose uptake, adipocyte hyperplasia in the presence of mitochondrial dysfunction, altered autophagy, and local insulin resistance. Conclusions We discovered that the reduction of HSP60 in mice predominantly affects adipose tissue homeostasis, leading to beneficial alterations in body weight, body composition, and adipocyte morphology, albeit exhibiting local insulin resistance. KW - Mitochondria KW - Stress response KW - Obesity KW - Glucose homeostasis KW - Insulin resistance KW - Adipose tissue Y1 - 2021 U6 - https://doi.org/10.1016/j.molmet.2021.101276 SN - 2212-8778 VL - 53 SP - 1 EP - 14 PB - Elsevier CY - Amsterdam, Niederlande ER - TY - JOUR A1 - Stadion, Mandy A1 - Schürmann, Annette T1 - Intermittent fasting T1 - Intermittierendes Fasten BT - What effects does it have in humans? BT - Welche Effekte hat es beim Menschen? JF - Psychotherapeut N2 - A long-term positive energy balance leads to overweight and obesity. Adiposity is the main risk factor for cardiovascular diseases, type 2 diabetes and cancer and is often accompanied by depression. The increasing prevalence creates a major problem for the healthcare system. The conservative management of obesity strives for weight loss by reducing the daily caloric intake and increasing physical activity as well as an improvement in the quality of life supported by psychological interventions. For reducing body weight, intermittent fasting represents an alternative to continuous calorie restriction as it can be easily integrated into daily life. In this form of diet calorie intake is limited in time, i.e. on 2 days in the week or 6-10 h per day. Animal and human studies provide evidence that intermittent fasting over a longer time period is a suitable method to decrease body fat and to improve many metabolic parameters. Fasting alters metabolism and activates specific cellular pathways. These have not only cardioprotective effects but also neuroprotective and antidepressive effects. In this article the currently discussed mechanisms induced by intermittent fasting are highlighted and the essential observations from randomized controlled human trials are presented. KW - Obesity KW - Brain-derived neurotrophic factor KW - Insulin sensitivity KW - Metabolic flexibility KW - Circadian rhythm Y1 - 2020 U6 - https://doi.org/10.1007/s00278-020-00471-5 SN - 0935-6185 SN - 1432-2080 VL - 66 IS - 1 SP - 23 EP - 27 PB - Springer CY - New York ER - TY - THES A1 - Hauffe, Robert T1 - Investigating metabolic consequences of an HSP60 reduction during diet-induced obesity T1 - Metabolische Folgen einer HSP60 Reduktion während des Diät-induzierten Übergewichts N2 - The mitochondrial chaperone complex HSP60/HSP10 facilitates mitochondrial protein homeostasis by folding more than 300 mitochondrial matrix proteins. It has been shown previously that HSP60 is downregulated in brains of type 2 diabetic (T2D) mice and patients, causing mitochondrial dysfunction and insulin resistance. As HSP60 is also decreased in peripheral tissues in T2D animals, this thesis investigated the effect of overall reduced HSP60 in the development of obesity and associated co-morbidities. To this end, both female and male C57Bl/6N control (i.e. without further alterations in their genome, Ctrl) and heterozygous whole-body Hsp60 knock-out (Hsp60+/-) mice, which exhibit a 50 % reduction of HSP60 in all tissues, were fed a normal chow diet (NCD) or a highfat diet (HFD, 60 % calories from fat) for 16 weeks and were subjected to extensive metabolic phenotyping including indirect calorimetry, NMR spectroscopy, insulin, glucose and pyruvate tolerance tests, vena cava insulin injections, as well as histological and molecular analysis. Interestingly, NCD feeding did not result in any striking phenotype, only a mild increase in energy expenditure in Hsp60+/- mice. Exposing mice to a HFD however revealed an increased body weight due to higher muscle mass in female Hsp60+/- mice, with a simultaneous decrease in energy expenditure. Additionally, these mice displayed decreased fasting glycemia. Opposingly, male Hsp60+/- compared to control mice showed lower body weight gain due to decreased fat mass and an increased energy expenditure, strikingly independent of lean mass. Further, only male Hsp60+/- mice display improved HOMA-IR and Matsuda insulin sensitivity indices. Despite the opposite phenotype in regards to body weight development, Hsp60+/- mice of both sexes show a significantly higher cell number, as well as a reduction in adipocyte size in the subcutaneous and gonadal white adipose tissue (sc/gWAT). Curiously, this adipocyte hyperplasia – usually associated with positive aspects of WAT function – is disconnected from metabolic improvements, as the gWAT of male Hsp60+/- mice shows mitochondrial dysfunction, oxidative stress, and insulin resistance. Transcriptomic analysis of gWAT shows an up regulation of genes involved in macroautophagy. Confirmatory, expression of microtubuleassociated protein 1A/1B light chain 3B (LC3), as a protein marker of autophagy, and direct measurement of lysosomal activity is increased in the gWAT of male Hsp60+/- mice. In summary, this thesis revealed a novel gene-nutrient interaction. The reduction of the crucial chaperone HSP60 did not have large effects in mice fed a NCD, but impacted metabolism during DIO in a sex-specific manner, where, despite opposing body weight and body composition phenotypes, both female and male Hsp60+/- mice show signs of protection from high fat diet-induced systemic insulin resistance. N2 - Der mitochondriale Chaperonkomplex HSP60/10 ist für die korrekte Faltung von über 300 mitochondrialen Matrixproteinen verantwortlich. Es wurde bereits gezeigt, dass HSP60 in Gehirnen von Patienten sowie Mäusen mit Typ 2 Diabetes (T2D) reduziert ist, was zu mitochondrialer Dysfunktion und Insulinresistenz führt. HSP60 ist darüber hinaus auch in peripheren Organen von T2D Mäusen reduziert. Die hier vorliegende Arbeit hat daher den Einfluss einer generellen Reduktion von HSP60 auf die Entwicklung von Übergewicht und die damit assoziierten Komorbiditäten untersucht. Hierfür wurden weibliche und männliche C57Bl/6N Kontroll Mäuse (d.h. ohne wietere Veränderung ihres Genoms, Ctrl), sowie C57Bl/6N Mäuse mit einer heterozygoten Deletion von HSP60 (Hsp60+/-) genutzt. Die Hsp60+/- Maus zeigt eine 50 % Reduktion von HSP60 in allen Geweben. Allen Tieren wurde in der Folge entweder eine normale Haltungsdiät (NCD) oder eine 60 % Hochfettdiät (HFD) gefüttert und einer intensiven metabolischen Charakterisierung unterzogen. Dies beinhaltete indirekte Kalorimetrie, NMR Spektroskopie, Insulin, Glukose und Pyruvat Toleranztests, direkte vena cava Insulinapplikation, sowie eingehende histologische und molekulare Untersuchungen. Interessanterweise zeigte die Fütterung mit der NCD keine stark ausgeprägten Phänotypen, lediglich ein leichter Anstieg im Energieverbrauch war zu beobachten. Die Fütterung mit der HFD dagegen führte auf Grund von größerer Muskelmasse zu einem erhöhten Körpergewicht in weiblichen Hsp60+/- Mäusen, was mit gleichzeitig verringertem Energieverbrauch einherging. Zusätzlich war bei diesen Mäusen der gefastete Bluzuckerspiegel verringert. Im Gegensatz dazu zeigten männliche Hsp60+/- Mäuse ein verringertes Körpergewicht, bedingt durch eine geringere Fettmasse sowie erhöhtem Energieverbrauch. Darüber hinaus war bei männlichen Hsp60+/- Mäusen eine Verbesserung der Insulin Sensitivitätsindizes HOMA-IR und Matsuda Index zu verzeichnen. Trotz dieses gegenteiligen Phänotyps zeigten beide Geschlechter eine erhöhte Zellzahl, sowie eine verringerte Zellgröße der Adipozyten im subkutanen und gonadalen weißen Fettgewebe (sc/gWAT (engl: white adipose tissue)). Überraschenderweise ist diese Adipozytenhyperplasie – normalerweise assoziiert mit verbesserter Fettgewebsfunktion – losgelöst von verbesserter WAT Funktion, da das gWAT männlicher Hsp60+/- Mäuse mitochondriale Dysfunktion, oxidativen Stress und Insulinresistenz zeigt. Eine folgende Transkriptomanalyse gab Hinweise auf eine Induktion der Makroautophagie. Bestätigend hierfür ist im gWAT der heterozygoten Mäuse die Expression des Autophagie Markers microtubule-associated protein 1A/1B light chain 3B (LC3), sowie die direkt gemessene lysosomale Aktivität erhöht. Zusammenfassend konnte in dieser Arbeit eine neuartige Gen-Nährstoff Interaktion gezeigt werden. So zeigte die Reduktion des wichtigen Chaperons HSP60 unter NCD Fütterung nur schwache Effekte, während unter Hochfettdiätfütterung der Stoffwechsel geschlechtsspezifisch beinflusst wurde. Obwohl die beiden Geschlechter der Hsp60+/- Mäuse gegenteilige Phänotypen im Bezug auf Körpergewicht und Körperzusammensetzung aufwiesen, zeigen beide Anzeichen eines Schutzes vor Hochfettdiät-induzierter Insulinresistenz. KW - Obesity KW - Adipose tissue KW - Insulin resistance KW - Mitochondria KW - Fettgewebe KW - Insulinresistenz KW - Mitochondrien KW - Adipositas Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-509294 ER - TY - JOUR A1 - Warschburger, Petra A1 - Kröller, Katja T1 - Loss to follow-up in a randomized controlled trial study for pediatric weight management (EPOC) JF - BMC pediatrics N2 - Background Attrition is a serious problem in intervention studies. The current study analyzed the attrition rate during follow-up in a randomized controlled pediatric weight management program (EPOC study) within a tertiary care setting. Methods Five hundred twenty-three parents and their 7–13-year-old children with obesity participated in the randomized controlled intervention trial. Follow-up data were assessed 6 and 12 months after the end of treatment. Attrition was defined as providing no objective weight data. Demographic and psychological baseline characteristics were used to predict attrition at 6- and 12-month follow-up using multivariate logistic regression analyses. Results Objective weight data were available for 49.6 (67.0) % of the children 6 (12) months after the end of treatment. Completers and non-completers at the 6- and 12-month follow-up differed in the amount of weight loss during their inpatient stay, their initial BMI-SDS, educational level of the parents, and child’s quality of life and well-being. Additionally, completers supported their child more than non-completers, and at the 12-month follow-up, families with a more structured eating environment were less likely to drop out. On a multivariate level, only educational background and structure of the eating environment remained significant. Conclusions The minor differences between the completers and the non-completers suggest that our retention strategies were successful. Further research should focus on prevention of attrition in families with a lower educational background. KW - Attrition KW - Obesity KW - Child KW - Predictors KW - Weight management trial Y1 - 2016 U6 - https://doi.org/10.1186/s12887-016-0727-2 SN - 1471-2431 VL - 16 PB - BioMed Central CY - London ER - TY - GEN A1 - Warschburger, Petra A1 - Kröller, Katja T1 - Loss to follow-up in a randomized controlled trial study for pediatric weight management (EPOC) N2 - Background Attrition is a serious problem in intervention studies. The current study analyzed the attrition rate during follow-up in a randomized controlled pediatric weight management program (EPOC study) within a tertiary care setting. Methods Five hundred twenty-three parents and their 7–13-year-old children with obesity participated in the randomized controlled intervention trial. Follow-up data were assessed 6 and 12 months after the end of treatment. Attrition was defined as providing no objective weight data. Demographic and psychological baseline characteristics were used to predict attrition at 6- and 12-month follow-up using multivariate logistic regression analyses. Results Objective weight data were available for 49.6 (67.0) % of the children 6 (12) months after the end of treatment. Completers and non-completers at the 6- and 12-month follow-up differed in the amount of weight loss during their inpatient stay, their initial BMI-SDS, educational level of the parents, and child’s quality of life and well-being. Additionally, completers supported their child more than non-completers, and at the 12-month follow-up, families with a more structured eating environment were less likely to drop out. On a multivariate level, only educational background and structure of the eating environment remained significant. Conclusions The minor differences between the completers and the non-completers suggest that our retention strategies were successful. Further research should focus on prevention of attrition in families with a lower educational background. T3 - Zweitveröffentlichungen der Universität Potsdam : Humanwissenschaftliche Reihe - 307 KW - Attrition KW - Child KW - Obesity KW - Predictors KW - Weight management trial Y1 - 2016 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-100359 ER - TY - JOUR A1 - Warschburger, Petra A1 - Kröller, Katja T1 - Loss to follow-up in a randomized controlled trial study for pediatric weight management (EPOC) JF - BMC PEDIATRICS N2 - Background: Attrition is a serious problem in intervention studies. The current study analyzed the attrition rate during follow-up in a randomized controlled pediatric weight management program (EPOC study) within a tertiary care setting. Methods: Five hundred twenty-three parents and their 7-13-year-old children with obesity participated in the randomized controlled intervention trial. Follow-up data were assessed 6 and 12 months after the end of treatment. Attrition was defined as providing no objective weight data. Demographic and psychological baseline characteristics were used to predict attrition at 6- and 12-month follow-up using multivariate logistic regression analyses. Conclusions: The minor differences between the completers and the non-completers suggest that our retention strategies were successful. Further research should focus on prevention of attrition in families with a lower educational background. KW - Attrition KW - Obesity KW - Child KW - Predictors KW - Weight management trial Y1 - 2016 U6 - https://doi.org/10.1186/s12887-016-0727-2 SN - 1471-2431 VL - 16 PB - BioMed Central CY - London ER - TY - JOUR A1 - Schulze, Matthias Bernd T1 - Metabolic health in normal-weight and obese individuals JF - Diabetologia : journal of the European Association for the Study of Diabetes (EASD) N2 - Cardiovascular complications are commonly associated with obesity. However, a subgroup of obese individuals may not be at an increased risk for cardiovascular complications; these individuals are said to have metabolically healthy obesity (MHO). In contrast, metabolically unhealthy individuals are at high risk of cardiovascular disease (CVD), irrespective of BMI; thus, this group can include individuals within the normal weight category (BMI 18.5-24.9kg/m(2)). This review provides a summary of prospective studies on MHO and metabolically unhealthy normal-weight (MUHNW) phenotypes. Notably, there is ongoing dispute surrounding the concept of MHO, including the lack of a uniform definition and the potentially transient nature of metabolic health status. This review highlights the relevance of alternative measures of body fatness, specifically measures of fat distribution, for determining MHO and MUHNW. It also highlights alternative approaches of risk stratification, which account for the continuum of risk in relation to CVD, which is observable for most risk factors. Moreover, studies evaluating the transition from metabolically healthy to unhealthy phenotypes and potential determinants for such conversions are discussed. Finally, the review proposes several strategies for the use of epidemiological research to further inform the current debate on metabolic health and its determination across different stages of body fatness. KW - Cardiovascular diseases KW - Cohort studies KW - Metabolically benign KW - Obesity KW - Review Y1 - 0208 U6 - https://doi.org/10.1007/s00125-018-4787-8 SN - 0012-186X SN - 1432-0428 VL - 62 IS - 4 SP - 558 EP - 566 PB - Springer CY - New York ER - TY - JOUR A1 - Caliendo, Marco A1 - Gehrsitz, Markus T1 - Obesity and the labor market: A fresh look at the weight penalty JF - Inorganics : open access journal KW - Obesity KW - Wages KW - Employment KW - Semiparametric regression KW - Gender differences Y1 - 2016 U6 - https://doi.org/10.1016/j.ehb.2016.09.004 SN - 1570-677X SN - 1873-6130 VL - 23 SP - 209 EP - 225 PB - Elsevier CY - Amsterdam ER - TY - THES A1 - Leicht, Katja T1 - Positionelle Klonierung von Tbc1d1 als Kandidatengen für Adipositas T1 - Positional cloning of Tbc1d1 as candidate gene for obesity N2 - Nob1 (New Zealand obese 1) bezeichnet einen Adipositas-QTL auf Chr. 5 der Maus (LODBMI >3,3), der in einem Rückkreuzungsexperiment der Mausstämme NZO (adipös) und SJL (schlank) identifiziert wurde. Um Kandidatengene für Adipositas zu finden, wurden mehr als 300 Nob1-Transkripte mit Hilfe von Genexpressionsanalysen auf Unterschiede in stoffwechselrelevanten Geweben zwischen beiden Mausstämmen untersucht. Sieben Gene zeigten eine differentielle Expression: 2310045A20Rik, Tbc1d1, Ppp1cb, Mll5, Insig1, Abhd1 und Alox5ap. Die codierenden Bereiche dieser Gene wurden anschließend auf Sequenzunterschiede zwischen NZO und SJL untersucht. Nur im Gen Tbc1d1, das im Peak-Bereich des Nob1 lokalisiert ist, wurde eine SJL-spezifische Deletion von sieben Basen detektiert, die zu einer Leserasterverschiebung und einem vorzeitigen Abbruch des Proteins in der funktionellen Rab-GAP-Domäne führt (Loss-of-Function-Mutation). Interessanterweise wurde eine Variante von TBC1D1 (R125W) in Kopplungsanalysen mit Adipositas beim Menschen assoziiert (Stone et al., 2006). TBC1D1 zeigt eine hohe Homologie zu TBC1D4 (AS160), das im Insulinsignalweg eine wichtige Rolle spielt. In 17 weiteren Genen im Peak-Bereich des Nob1 wurde keine weitere SJL-spezifischen Mutation detektiert. Bei NZO-Tieren erfolgte die Tbc1d1-mRNA-Expression vorwiegend in glycolytischen Fasern des Skelettmuskels. Zudem wurden zwei gewebsspezifisch exprimierte Tbc1d1-Isoformen identifiziert, die sich durch alternatives Splicen der Exone 12 und 13 unterscheiden. Die im Rahmen dieser Arbeit gefundenen Ergebnisse machen Tbc1d1 zu einem plausiblen Kandidatengen für den Nob1-QTL. Welche Funktion Tbc1d1 im Glucose- und Fettstoffwechsel des Skelettmuskels hat, muss in weiteren Analysen untersucht werden. N2 - Nob1 (New Zealand obese 1) has been identified as an obesity QTL on chromosome 5 (LODBMI >3,3) in a backcross experiment of obese NZO and lean SJL mice. To identify candidate genes for obesity expression profiling experiments with RNA from metabolic tissues were performed with more than 300 Nob1-genes. Seven genes showed differences in mRNA expression levels between both strains: 2310045A20Rik, Tbc1d1, Ppp1cb, Mll5, Insig1, Abhd1, and Alox5ap. Sequencing of the coding regions of these genes revealed a SJL-specific deletion of seven basepairs in the Tbc1d1 gene that is located in the peak region of Nob1. This mutation leads to a frameshift resulting in a truncated protein that lacks the important Rab-GAP-domain (Loss-of-Function-mutation). Interestingly, linkage analysis of the R125W-variant of TBC1D1 has been recently associated with human obesity. TBC1D1 shows high homology to TBC1D4 (AS160) that plays an important role in the insulin signaling pathway. No other SJL-specific mutations were detected in 17 further genes in the Nob1 peak region. In NZO mice Tbc1d1 mRNA is predominantly expressed in glycolytic fibres of skeletal muscle. Two isoformes were identified differing in alternative spliced exons 12 and 13 and showing a tissue specific mRNA expression. The results presented in this work make Tbc1d1 a very feasible candidate gene to be causal for Nob1. The function of Tbc1d1 in the metabolism of carbohydrates and fat has yet to be analyzed. KW - Tbc1d1 KW - Adipositas KW - SJL KW - loss-of-function-Mutation KW - QTL KW - Tbc1d1 KW - Obesity KW - SJL KW - loss-of-function mutation KW - QTL Y1 - 2008 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus-34610 ER - TY - JOUR A1 - Warschburger, Petra A1 - Kuhne, Daniela T1 - Psychosocial determinants of quality of life in parents of obese children seeking inpatient treatment JF - Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation N2 - To examine and identify predictors of parental health-related quality of life (HRQoL) in a sample of obese and very obese children participating in an inpatient program for treating obesity. KW - Health-related quality of life KW - Obesity KW - Parents KW - Children KW - Self-efficacy Y1 - 2014 U6 - https://doi.org/10.1007/s11136-014-0659-y SN - 0962-9343 SN - 1573-2649 VL - 23 IS - 7 SP - 1985 EP - 1995 PB - Springer CY - Dordrecht ER - TY - THES A1 - Seebeck, Nicole T1 - Regulation of the organokines FGF21 and chemerin by diet BT - metabolic and molecular effects in liver and adipose tissue of obese human subjects BT - metabolische und molekulare Effekte in Leber und Fettgewebe adipöser humaner Probanden N2 - The hepatokine FGF21 and the adipokine chemerin have been implicated as metabolic regulators and mediators of inter-tissue crosstalk. While FGF21 is associated with beneficial metabolic effects and is currently being tested as an emerging therapeutic for obesity and diabetes, chemerin is linked to inflammation-mediated insulin resistance. However, dietary regulation of both organokines and their role in tissue interaction needs further investigation. The LEMBAS nutritional intervention study investigated the effects of two diets differing in their protein content in obese human subjects with non-alcoholic fatty liver disease (NAFLD). The study participants consumed hypocaloric diets containing either low (LP: 10 EN%, n = 10) or high (HP: 30 EN%, n = 9) dietary protein 3 weeks prior to bariatric surgery. Before and after the intervention the participants were anthropometrically assessed, blood samples were drawn, and hepatic fat content was determined by MRS. During bariatric surgery, paired subcutaneous and visceral adipose tissue biopsies as well as liver biopsies were collected. The aim of this thesis was to investigate circulating levels and tissue-specific regulation of (1) FGF21 and (2) chemerin in the LEMBAS cohort. The results were compared to data obtained in 92 metabolically healthy subjects with normal glucose tolerance and normal liver fat content. (1) Serum FGF21 concentrations were elevated in the obese subjects, and strongly associated with intrahepatic lipids (IHL). In accordance, FGF21 serum concentrations increased with severity of NAFLD as determined histologically in the liver biopsies. Though both diets were successful in reducing IHL, the effect was more pronounced in the HP group. FGF21 serum concentrations and mRNA expression were bi-directionally regulated by dietary protein, independent from metabolic improvements. In accordance, in the healthy study subjects, serum FGF21 concentrations dropped by more than 60% in response to the HP diet. A short-term HP intervention confirmed the acute downregulation of FGF21 within 24 hours. Lastly, experiments in HepG2 cell cultures and primary murine hepatocytes identified nitrogen metabolites (NH4Cl and glutamine) to dose-dependently suppress FGF21 expression. (2) Circulating chemerin concentrations were considerably elevated in the obese versus lean study participants and differently associated with markers of obesity and NAFLD in the two cohorts. The adipokine decreased in response to the hypocaloric interventions while an unhealthy high-fat diet induced a rise in chemerin serum levels. In the lean subjects, mRNA expression of RARRES2, encoding chemerin, was strongly and positively correlated with expression of several cytokines, including MCP1, TNFα, and IL6, as well as markers of macrophage infiltration in the subcutaneous fat depot. However, RARRES2 was not associated with any cytokine assessed in the obese subjects and the data indicated an involvement of chemerin not only in the onset but also resolution of inflammation. Analyses of the tissue biopsies and experiments in human primary adipocytes point towards a role of chemerin in adipogenesis while discrepancies between the in vivo and in vitro data were detected. Taken together, the results of this thesis demonstrate that circulating FGF21 and chemerin levels are considerably elevated in obesity and responsive to dietary interventions. FGF21 was acutely and bi-directionally regulated by dietary protein in a hepatocyte-autonomous manner. Given that both, a lack in essential amino acids and excessive nitrogen intake, exert metabolic stress, FGF21 may serve as an endocrine signal for dietary protein balance. Lastly, the data revealed that chemerin is derailed in obesity and associated with obesity-related inflammation. However, future studies on chemerin should consider functional and regulatory differences between secreted and tissue-specific isoforms. N2 - Extremes Übergewicht einhergehend mit einer starken Vermehrung des Körperfetts (Adipositas) stellt ein weltweites Gesundheitsproblem dar und geht oft mit assoziierten Erkrankungen, wie Diabetes, einer Fettleber und Herz-Kreislauf-Erkrankungen einher. Die Ernährung spielt in der Entstehung und Therapie der Adipositas eine zentrale Rolle. Gerät der Stoffwechsel aufgrund anhaltender Energieüberschüsse aus dem Gleichgewicht, werden von Leber und Fettgewebe Entzündungsmarker sowie Signalmoleküle, darunter Chemerin und FGF21, ausgesendet. Während vorhergehende Studien für FGF21 vorteilhafte Effekte auf den Zucker- und Energiestoffwechsel demonstriert haben, steht Chemerin im Zusammenhang mit der Entwicklung chronisch-entzündlicher Erkrankungen. Die vorliegende Arbeit untersucht die nahrungsabhängige Regulation von FGF21 und Chemerin in humanen Blut-, Leber- und Fettgewebsproben aus stark übergewichtigen Probanden, um ein besseres Verständnis für die Physiologie der beiden Moleküle zu gewinnen. Die Studienteilnehmer konsumierten drei Wochen vor bariatrischer Operation zwei kalorienreduzierte Diäten, die sich in ihrem Proteinanteil (10% versus 30% der Gesamtenergie) unterschieden. Vor und nach der Diätintervention wurde die körperliche Konstitution und der Leberfettanteil der Probanden bestimmt sowie klinische Marker im Blut ermittelt. Während der bariatrischen Operation wurden zudem Leber- und Fettgewebsbiopsien entnommen. Die Ergebnisse wurden bezüglich der Regulation von FGF21 und Chemerin ausgewertet und anschließend mit Daten von gesunden, schlanken Probanden verglichen. FGF21 war in den adipösen Probanden deutlich erhöht und wies eine starke Assoziation mit dem Leberfettgehalt auf. Beide Diäten konnten das Leberfett deutlich senken, wobei die Hochproteindiät effektiver war. Die FGF21 Blutspiegel sanken mit steigender Proteinaufnahme, was sich auch in der hepatischen Genexpression widerspiegelte. Zellkulturversuche bestätigten eine negative Regulation von FGF21 durch Zwischenprodukte des Proteinstoffwechsels. Zusammenfassend zeigen die Ergebnisse, dass eine Hochproteindiät FGF21 kurzfristig und dosisabhängig supprimiert bei gleichzeitiger Verbesserung der Stoffwechsellage. Chemerin war in den übergewichtigen und gesunden Probanden unterschiedlich mit Markern der Adipositas und der Fettlebererkrankung assoziiert. Zudem konnte eine ernährungsabhängige Regulation von Chemerin aufgezeigt werden, wobei der Proteingehalt der Diät unerheblich war. Interessanterweise deuten die Daten aus den Fettgewebsbiopsien auf eine Rolle von Chemerin sowohl in der Entstehung als auch in der Auflösung entzündlicher Vorgänge hin. Die Ergebnisse dieser Arbeit zeigen, dass Chemerin im Zusammenhang mit der Entwicklung der Adipositas steht aber auch günstige Effekte auf dessen Verlauf haben könnte. T2 - Regulation der Organokine FGF21 und Chemerin durch Ernährung KW - Obesity KW - FGF21 KW - Chemerin KW - Adipositas Y1 - 2020 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus4-471140 ER -